Ixazomib Active Not Recruiting Phase 3 Trials for Multiple Myeloma (MM) / Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04371770Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)